LIMES SCHLOSSKLINIKEN AG (LIK.DE) Stock Fundamental Analysis
FRA:LIK - DE000A0JDBC7 - Common Stock
390 EUR
-2 (-0.51%)
LIK gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 28 industry peers in the Health Care Providers & Services industry. LIK gets an excellent profitability rating and is at the same time showing great financial health properties. LIK is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make LIK a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
LIK had positive earnings in the past year.
In multiple years LIK reported negative net income over the last 5 years.
In multiple years LIK reported negative operating cash flow during the last 5 years.
1.2 Ratios
LIK has a Return On Assets of 12.97%. This is amongst the best in the industry. LIK outperforms 100.00% of its industry peers.
The Return On Equity of LIK (25.18%) is better than 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 16.32%, LIK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
LIK had an Average Return On Invested Capital over the past 3 years of 20.25%. This is significantly above the industry average of 6.48%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.97% | ||
| ROE | 25.18% | ||
| ROIC | 16.32% |
ROA(3y)15.82%
ROA(5y)6.58%
ROE(3y)41.01%
ROE(5y)14.54%
ROIC(3y)20.25%
ROIC(5y)N/A
1.3 Margins
LIK has a better Profit Margin (9.95%) than 100.00% of its industry peers.
With an excellent Operating Margin value of 12.65%, LIK belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
LIK has a better Gross Margin (95.44%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of LIK has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.65% | ||
| PM (TTM) | 9.95% | ||
| GM | 95.44% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y0.44%
2. Health
2.1 Basic Checks
LIK has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
LIK has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, LIK has more shares outstanding
Compared to 1 year ago, LIK has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 6.61 indicates that LIK is not in any danger for bankruptcy at the moment.
The Altman-Z score of LIK (6.61) is better than 100.00% of its industry peers.
LIK has a Debt/Equity ratio of 0.51. This is a neutral value indicating LIK is somewhat dependend on debt financing.
LIK's Debt to Equity ratio of 0.51 is amongst the best of the industry. LIK outperforms 82.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.51 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.61 |
ROIC/WACC2.33
WACC7.01%
2.3 Liquidity
LIK has a Current Ratio of 3.45. This indicates that LIK is financially healthy and has no problem in meeting its short term obligations.
LIK has a better Current ratio (3.45) than 100.00% of its industry peers.
LIK has a Quick Ratio of 3.43. This indicates that LIK is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of LIK (3.43) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.43 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 33.36% over the past year.
LIK shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.82%.
LIK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.61% yearly.
EPS 1Y (TTM)33.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.75%
Revenue 1Y (TTM)39.82%
Revenue growth 3Y50.34%
Revenue growth 5Y38.61%
Sales Q2Q%35.88%
3.2 Future
LIK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.41% yearly.
LIK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.84% yearly.
EPS Next Y51.17%
EPS Next 2Y53.16%
EPS Next 3Y41.41%
EPS Next 5YN/A
Revenue Next Year15.52%
Revenue Next 2Y22.23%
Revenue Next 3Y20.84%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
LIK is valuated quite expensively with a Price/Earnings ratio of 26.44.
Based on the Price/Earnings ratio, LIK is valued a bit more expensive than 64.29% of the companies in the same industry.
LIK's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.03.
LIK is valuated correctly with a Price/Forward Earnings ratio of 14.19.
LIK's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LIK is cheaper than 64.29% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.63. LIK is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.44 | ||
| Fwd PE | 14.19 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LIK is valued a bit more expensive than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.05 |
4.3 Compensation for Growth
LIK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of LIK may justify a higher PE ratio.
LIK's earnings are expected to grow with 41.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.52
PEG (5Y)N/A
EPS Next 2Y53.16%
EPS Next 3Y41.41%
5. Dividend
5.1 Amount
No dividends for LIK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:LIK (9/3/2025, 7:00:00 PM)
390
-2 (-0.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap113.10M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.44 | ||
| Fwd PE | 14.19 | ||
| P/S | 2.63 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 7.07 | ||
| P/tB | 17.59 | ||
| EV/EBITDA | 15.05 |
EPS(TTM)14.75
EY3.78%
EPS(NY)27.49
Fwd EY7.05%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS148.28
BVpS55.17
TBVpS22.17
PEG (NY)0.52
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.97% | ||
| ROE | 25.18% | ||
| ROCE | 18.99% | ||
| ROIC | 16.32% | ||
| ROICexc | 16.32% | ||
| ROICexgc | 24.51% | ||
| OM | 12.65% | ||
| PM (TTM) | 9.95% | ||
| GM | 95.44% | ||
| FCFM | N/A |
ROA(3y)15.82%
ROA(5y)6.58%
ROE(3y)41.01%
ROE(5y)14.54%
ROIC(3y)20.25%
ROIC(5y)N/A
ROICexc(3y)28.07%
ROICexc(5y)N/A
ROICexgc(3y)81.25%
ROICexgc(5y)N/A
ROCE(3y)23.56%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y0.44%
F-ScoreN/A
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.51 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.07 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.45 | ||
| Quick Ratio | 3.43 | ||
| Altman-Z | 6.61 |
F-ScoreN/A
WACC7.01%
ROIC/WACC2.33
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.75%
EPS Next Y51.17%
EPS Next 2Y53.16%
EPS Next 3Y41.41%
EPS Next 5YN/A
Revenue 1Y (TTM)39.82%
Revenue growth 3Y50.34%
Revenue growth 5Y38.61%
Sales Q2Q%35.88%
Revenue Next Year15.52%
Revenue Next 2Y22.23%
Revenue Next 3Y20.84%
Revenue Next 5YN/A
EBIT growth 1Y12.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.82%
EBIT Next 3Y49.06%
EBIT Next 5Y35.28%
FCF growth 1Y-104.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.8%
OCF growth 3YN/A
OCF growth 5YN/A